[ad_1]
Researchers from the “Senovac Beauty” laboratory confirmedSinovac Biotech In Beijing, the company is preparing to produce 100 million doses of a vaccine that began recently as a human experiment after its success in animal testing, according to “Russia Today.”.
The company is currently conducting 4 clinical trials on the vaccine whose size does not exceed half a milliliter after it was shown to be effective in monkeys..
Thousands of packages of the vaccine produced and based on the generation of inert parasites were packed and packed in white and orange packages with the name “Koronavac”(Coronavac) In her.
The company sent large batches of the vaccine to Chinese medical authorities for approvals, but the company shows that it can produce it on a large scale in very large quantities..
The company confirmed that the vaccine left no clear side effect in the monkeys, and that the laboratory began human testing on April 16..
Researchers from the “Senovac Biotic” laboratory gave two different doses of the vaccine to a total of eight rhesus monkeys, and after three weeks, they inserted the dose of the SARS virus into the monkeys’ lungs. CoV-2, Which is the virus that causes “Covid-19”, through the tubes under the trachea, and none of them have been fully infected, according to the agency “AFP”“
The monkeys that received the highest dose had a good response. After 7 days of receiving the virus infection, the researchers found no trace of it in the monkeys’ pharynx or lungs..
Liu Beicheng, manager of Sinovac, said the company did not know exactly when it could distribute the vaccine, according to “AFP”.“
“The results” give us a lot of confidence “that the vaccine will affect humans,” Meng Winning, senior director of foreign regulatory affairs at Sinovac, said in press statements issued by local media..
